Technical Analysis for ABVX - ABIVAX Société Anonyme
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Stochastic Sell Signal | Bearish | -0.48% | |
Overbought Stochastic | Strength | -0.48% | |
Down 3 Days in a Row | Weakness | -0.48% | |
Weak + Overbought | Other | -2.10% | |
Overbought Stochastic | Strength | -2.10% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.11% | |
Weak + Overbought | Other | -3.11% |
Alert | Time |
---|---|
2x Volume Pace | about 23 hours ago |
1.5x Volume Pace | about 23 hours ago |
3x Volume Pace | about 23 hours ago |
Fell Below Previous Day's Low | about 23 hours ago |
Down 1% | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Gastroenterology Colitis Diarrhea
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Gastroenterology Colitis Diarrhea
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 17.02 |
52 Week Low | 8.75 |
Average Volume | 124,740 |
200-Day Moving Average | 12.81 |
50-Day Moving Average | 10.96 |
20-Day Moving Average | 10.04 |
10-Day Moving Average | 10.44 |
Average True Range | 0.44 |
RSI (14) | 46.52 |
ADX | 18.57 |
+DI | 22.89 |
-DI | 19.61 |
Chandelier Exit (Long, 3 ATRs) | 9.65 |
Chandelier Exit (Short, 3 ATRs) | 10.06 |
Upper Bollinger Bands | 11.11 |
Lower Bollinger Band | 8.97 |
Percent B (%b) | 0.61 |
BandWidth | 21.26 |
MACD Line | -0.09 |
MACD Signal Line | -0.17 |
MACD Histogram | 0.0842 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 10.56 | ||||
Resistance 3 (R3) | 10.57 | 10.48 | 10.51 | ||
Resistance 2 (R2) | 10.48 | 10.41 | 10.48 | 10.49 | |
Resistance 1 (R1) | 10.38 | 10.37 | 10.34 | 10.37 | 10.48 |
Pivot Point | 10.29 | 10.29 | 10.27 | 10.29 | 10.29 |
Support 1 (S1) | 10.19 | 10.22 | 10.15 | 10.18 | 10.06 |
Support 2 (S2) | 10.10 | 10.18 | 10.10 | 10.05 | |
Support 3 (S3) | 10.00 | 10.10 | 10.03 | ||
Support 4 (S4) | 9.99 |